SeaStar Medical, Selective Cytopheretic Device, SCD, Breakthrough Device Designation, FDA, Sepsis, Hyperinflammation, Acute Kidney Injury, AKI, Septic Condition, Critical Care,

DENVER — October 7, 2026 SeaStar Medical announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough...